Company: IMNN
Filing Date: 2025-06-09
Form Type: DEF 14A
Source: 0001641172-25-014324
Chunk: 24

Company: Imunon, Inc.
Filing Date: 2025-06-09
Form: DEF 14A
Chunk 24
---
 of Directors is properly constituted to meet its corporate governance obligations. Our Nominating and Governance Committee operates under a written charter that is available on our web site, located at www.imunon.com. The current members of our Nominating and Governance Committee are Dr. Donald P. Braun and Mr. James A. Dentzer. Our Board has determined that Dr. Braun and Mr. Dentzer are deemed to be independent under applicable Nasdaq rules.

Science and Technology Committee

The primary purpose of our Science and Technology Committee is to assist our Board of Directors in monitoring the state of science and technology capabilities within our Company and associated risks and overseeing the development of key technologies and major science and medicine-driven innovation initiatives essential to our long-term success. Our Science and Technology Committee’s responsibilities includes reviewing technologies and technology programs of significance to us, with special focus on major external initiatives, observing the evolution of science and medicine outside the Company, participating in the development of metrics to assess the state of our science and technology in subject areas including, but not limited to, patent estate, freedom to operate, productivity, capability and external benchmarks, providing guidance for our external science and technology alliances, and providing guidance on the direction of our science and technology activities, as appropriate. The current members of our Science and Technology Committee are Dr. Donald P. Braun (Chair) and Dr. Stacy R. Lindborg.

| 18 |

Meetings of the Board And its Committees

During the year ended December 31, 2024, there were a total of five regular meetings of our Board. All of our directors attended all of the meetings of our Board and the Board committees on which they served that were held during the period for which they were a director or committee member, respectively.

During the year ended December 31, 2024, our Audit Committee met four times, our Compensation Committee met one time, and our Nominating and Governance Committee met one time. Our Science and Technology Committee did not meet during 2024.

Director Nominations

The role of our Nominating and Governance Committee is to act on behalf of our Board of Directors to ensure that our Board of Directors and its standing committees are appropriately constituted to meet their fiduciary and corporate governance obligations. In this role, our Nominating and Governance Committee is responsible for identifying and recruiting new members of our Board of Directors when vacancies arise, identifying and recruiting nominees for election as directors and reconsidering incumbent directors in connection with nominations for elections of directors. Our Nominating and Governance Committee